Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Human papillomavirus (HPV) vaccine is recommended for adolescents. By the end of 2013, 64% of female and 40% of male New York City residents aged 13-18 years had received ≥1 HPV vaccine dose. Adolescents attending sexually transmitted disease (STD) clinics are at high risk for HPV exposure and could benefit from vaccination. Our objective was to estimate HPV vaccination coverage for this population.



We matched records of New York City's STD clinic patients aged 13-18 years during 2010-2013 with the Citywide Immunization Registry. We assessed HPV vaccine initiation (≥1 dose) and series completion (≥3 doses among those who initiated) as of clinic visit date and by patient demographics. We compared receipt of ≥1 dose for HPV, tetanus-diphtheria-acellular pertussis, and meningococcal conjugate vaccine.



Eighty-two percent of clinic attendees (13,505/16,364) had records in the Citywide Immunization Registry. Receipt of ≥1 HPV dose increased during 2010-2013 (females: 57.6%-69.7%; males: 1.5%-36.3%). Among females, ≥1-dose coverage was lowest among whites (53.4%) and highest among Hispanics (73.3%); among males, ≥1-dose coverage was lowest among whites (6.9%) and highest among Asians (20.9%). Series completion averaged 57.7% (females) and 28.0% (males), with little variation by race/ethnicity or poverty level. Receipt of ≥1 dose was 59.7% for HPV, 82% for tetanus-diphtheria-acellular pertussis, and 76% for meningococcal conjugate vaccines.



HPV vaccine initiation and completion were low among adolescent STD clinic patients; coverage was lower compared with other recommended vaccines. STD clinics may be good venues for delivering HPV vaccine, thereby enhancing efforts to improve HPV vaccination.
New York City Department of Health and Mental Hygiene, Bureau of Sexually Transmitted Disease Control, Queens, New York. Electronic address: ppathela@health.nyc.gov.
Preeti
P
Pathela
New York City Department of Health and Mental Hygiene, Bureau of Sexually Transmitted Disease Control, Queens, New York.
Kelly
K
Jamison
New York City Department of Health and Mental Hygiene, Bureau of Immunization, Queens, New York.
Vikki
V
Papadouka
New York City Department of Health and Mental Hygiene, Bureau of Immunization, Queens, New York.
Rezaul
R
Kabir
Division of Sexually Transmitted Diseases Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Lauri E
LE
Markowitz
Division of Sexually Transmitted Diseases Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Eileen F
EF
Dunne
New York City Department of Health and Mental Hygiene, Bureau of Sexually Transmitted Disease Control, Queens, New York; Division of Sexually Transmitted Diseases Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Julia A
JA
Schillinger
D000293:Adolescent; D000554:Ambulatory Care Facilities / Q000706:statistics & numerical data*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D008297:Male; D009519:New York City; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D012042:Registries; D014611:Vaccination / Q000706:statistics & numerical data*
D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D053918:Papillomavirus Vaccines
Adolescents; HPV vaccination; Immunization registry; STD clinics